Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harbinder Singh

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Journal of Biotechnology and Biomedicine|December 5, 2023
Discovery of Potential RAGE inhibitors using Receptor-Based Pharmacophore Modeling, High Throughput Virtual Screening and Docking StudiesHarbinder Singh, Devendra K Agrawal
Bioorganic & Medicinal Chemistry|April 1, 2022
Recent advances in the development of active hybrid molecules in the treatment of cardiovascular diseasesHarbinder Singh, Devendra K Agrawal
Drug Development Research|July 5, 2022
Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitorsHarbinder Singh, Devendra K Agrawal
Molecules (Basel, Switzerland)|November 11, 2022
Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory DiseasesHarbinder Singh, Devendra K Agrawal
Future Medicinal Chemistry|September 1, 2022
Recent advancements in the discovery of cereblon-based protease-targeted chimeras with potential for therapeutic interventionHarbinder Singh, Devendra K Agrawal
Thescientificworldjournal|April 1, 2014
A novel approach for detail-enhanced exposure fusion using guided filterHarbinder Singh, Vinay Kumar, Sunil Bhooshan
Anti-Cancer Agents in Medicinal Chemistry|January 19, 2019
Multi-Targeting Anticancer Agents: Rational Approaches, Synthetic Routes and Structure Activity RelationshipHarbinder Singh, Nihar Kinarivala, Sahil Sharma
Expert Opinion on Therapeutic Patents|May 31, 2021
Discerning the promising binding sites of S100/calgranulins and their therapeutic potential in atherosclerosisHarbinder Singh, Vikrant Rai, Devendra K Agrawal
International Journal of Molecular Sciences|October 14, 2022
Targeting the Crosstalk of Immune Response and Vascular Smooth Muscle Cells Phenotype Switch for Arteriovenous Fistula MaturationVikrant Rai, Harbinder Singh, Devendra K Agrawal
Molecular Biology Reports|June 30, 2022
LPS and oxLDL-induced S100A12 and RAGE expression in carotid arteries of atherosclerotic Yucatan microswineHarbinder Singh, Vikrant Rai, Devendra K Agrawal
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Journal of Biotechnology and Biomedicine|December 5, 2023
Discovery of Potential RAGE inhibitors using Receptor-Based Pharmacophore Modeling, High Throughput Virtual Screening and Docking StudiesHarbinder Singh, Devendra K Agrawal
Bioorganic & Medicinal Chemistry|April 1, 2022
Recent advances in the development of active hybrid molecules in the treatment of cardiovascular diseasesHarbinder Singh, Devendra K Agrawal
Drug Development Research|July 5, 2022
Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitorsHarbinder Singh, Devendra K Agrawal
Molecules (Basel, Switzerland)|November 11, 2022
Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory DiseasesHarbinder Singh, Devendra K Agrawal
Future Medicinal Chemistry|September 1, 2022
Recent advancements in the discovery of cereblon-based protease-targeted chimeras with potential for therapeutic interventionHarbinder Singh, Devendra K Agrawal
Thescientificworldjournal|April 1, 2014
A novel approach for detail-enhanced exposure fusion using guided filterHarbinder Singh, Vinay Kumar, Sunil Bhooshan
Anti-Cancer Agents in Medicinal Chemistry|January 19, 2019
Multi-Targeting Anticancer Agents: Rational Approaches, Synthetic Routes and Structure Activity RelationshipHarbinder Singh, Nihar Kinarivala, Sahil Sharma
Expert Opinion on Therapeutic Patents|May 31, 2021
Discerning the promising binding sites of S100/calgranulins and their therapeutic potential in atherosclerosisHarbinder Singh, Vikrant Rai, Devendra K Agrawal
International Journal of Molecular Sciences|October 14, 2022
Targeting the Crosstalk of Immune Response and Vascular Smooth Muscle Cells Phenotype Switch for Arteriovenous Fistula MaturationVikrant Rai, Harbinder Singh, Devendra K Agrawal
Molecular Biology Reports|June 30, 2022
LPS and oxLDL-induced S100A12 and RAGE expression in carotid arteries of atherosclerotic Yucatan microswineHarbinder Singh, Vikrant Rai, Devendra K Agrawal
Pageof 7